Quest Diagnostics (DGX) Form 3 QUEST DIAGNOSTICS / MICHAEL J DEPPE ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

DEPPE MICHAEL J

(Last) (First) (Middle)

500 PLAZA DRIVE

(Street)

SECAUCUS NJ 07094

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2019

3. Issuer Name and Ticker or Trading Symbol
QUEST DIAGNOSTICS INC [ DGX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP, Corp. Controller & CAO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,558	D
401(k)	615(1)	I	401(k)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualifed Stock Option (right to buy)	(2)	02/10/2020	Common Stock	5,000	55.65	D
Non-Qualifed Stock Option (right to buy)	(2)	02/15/2021	Common Stock	4,750	56.82	D
Non-Qualifed Stock Option (right to buy)	(2)	02/19/2028	Common Stock	5,515	103.57	D
Non-Qualifed Stock Option (right to buy)	(2)	02/18/2029	Common Stock	7,021	86.63	D
Non-Qualifed Stock Option (right to buy)	(2)	02/21/2027	Common Stock	6,261	95.795	D
Non-Qualifed Stock Option (right to buy)	(2)	02/25/2023	Common Stock	6,371	56.12	D
Non-Qualifed Stock Option (right to buy)	(2)	02/25/2026	Common Stock	10,120	66.51	D
Non-Qualifed Stock Option (right to buy)	(2)	02/22/2022	Common Stock	5,700	57.605	D
Non-Qualifed Stock Option (right to buy)	(2)	02/23/2025	Common Stock	8,635	71.17	D
Non-Qualifed Stock Option (right to buy)	(2)	02/13/2024	Common Stock	9,126	52.165	D

Explanation of Responses:

1. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

2. The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Remarks:

	William J. O'Shaughnessy, Jr. Attorney in Fact for Michael J. Deppe	04/03/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.